Elanco Animal Health Inc [ELAN] stock is trading at $12.45, up 5.06%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ELAN shares have lost -3.49% over the last week, with a monthly amount drifted -10.69%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Elanco Animal Health Inc [NYSE: ELAN] stock has seen the most recent analyst activity on January 05, 2024, when Stifel upgraded its rating to a Buy and also boosted its price target to $20 from $13. Previously, Jefferies started tracking the stock with Buy rating on December 19, 2023, and set its price target to $17. On December 15, 2023, upgrade upgraded it’s rating to Overweight but maintained its price target of $16 on the stock. Exane BNP Paribas started tracking the stock assigning a Outperform rating and suggested a price target of $18 on December 07, 2023. Barclays upgraded its rating to a Overweight but $14 remained the price target by the analyst firm on April 20, 2023. Morgan Stanley downgraded its rating to Equal-Weight for this stock on August 18, 2022, and downed its price target to $22. In a note dated August 16, 2022, JP Morgan downgraded an Neutral rating on this stock and revised its target price from $28 to $24.
Elanco Animal Health Inc [ELAN] stock has fluctuated between $8.52 and $18.80 over the past year. Currently, Wall Street analysts expect the stock to reach $25.83 within the next 12 months. Elanco Animal Health Inc [NYSE: ELAN] shares were valued at $12.45 at the most recent close of the market. An investor can expect a potential return of 107.47% based on the average ELAN price forecast.
Analyzing the ELAN fundamentals
Elanco Animal Health Inc [NYSE:ELAN] reported sales of 4.37B for the trailing twelve months, which represents a drop of -4.14%. Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at -0.3%, and Net Profit Margin reading is -0.3%. To continue investigating profitability, this company’s Return on Assets is posted at -0.09, Equity is -0.2 and Total Capital is 0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.95.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.08 points at the first support level, and at 11.71 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.69, and for the 2nd resistance point, it is at 12.92.
Ratios To Look Out For
For context, Elanco Animal Health Inc’s Current Ratio is 3.29. Further, the Quick Ratio stands at 1.96, while the Cash Ratio is 0.28. Considering the valuation of this stock, the price to sales ratio is 1.41, the price to book ratio is 1.02.
Transactions by insiders
Recent insider trading involved DOYLE WILLIAM F, Director, that happened on May 21 ’24 when 15000.0 shares were purchased. Director, DOYLE WILLIAM F completed a deal on Mar 08 ’24 to buy 15000.0 shares. Meanwhile, Director Harrington Michael J bought 3100.0 shares on Mar 08 ’24.
